Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Sumitomo presents new muscarinic M3 antagonists for use in urinary incontinence

April 7, 2003

ACS news: inhibitors of phosphate transport for use in patients with chronic renal disease

April 2, 2003

Oxytocin agonists with utility in erectile dysfunction claimed by Ferring

April 1, 2003

BioXell commences phase II trial of BXL-628

March 31, 2003

Bayer presents novel VR1 antagonists for urinary incontinence, pain, etc.

March 26, 2003

Potent alpha-adrenoceptor antagonists with utility in sexual dysfunction

March 25, 2003

New data on the safety profile of tadalafil in erectile dysfunction

March 21, 2003

Zelandopam prevents cisplatin-induced renal failure in rats

March 21, 2003

Novartis to acquire Pfizer incontinence drug

March 20, 2003

Calcimimetic reduces PTH levels in hyperparathyroidism secondary to hemodialysis

March 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...